The Current Ratio as of September 2024 (TTM) for Fresh Tracks Therapeutics, Inc. (FRTX) is 6.98

According to Fresh Tracks Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 6.98. This represents a change of 16.17% compared to the average of 6.00 of the last 4 quarters.

Fresh Tracks Therapeutics, Inc. (FRTX) Historical Current Ratio (quarterly & annually)

How has FRTX Current Ratio performed in the past?

The mean historical Current Ratio of Fresh Tracks Therapeutics, Inc. over the last ten years is 6.89. The current 6.98 Current Ratio has changed 10.02% with respect to the historical average. Over the past ten years (40 quarters), FRTX's Current Ratio was at its highest in in the June 2019 quarter at 36.84. The Current Ratio was at its lowest in in the December 2019 quarter at 1.71.

Fresh Tracks Therapeutics, Inc. (FRTX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Fresh Tracks Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Fresh Tracks Therapeutics, Inc. (FRTX) Average Current Ratio

How has FRTX Current Ratio performed in the past?

The current Current Ratio of Fresh Tracks Therapeutics, Inc. (FRTX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Fresh Tracks Therapeutics, Inc. (FRTX) Current Ratio vs. Peers

How is FRTX’s Current Ratio compared to its peers?

Fresh Tracks Therapeutics, Inc.’s Current Ratio is greater than Assembly Biosciences, Inc. (2.74), less than Instil Bio, Inc. (15.06), less than Nuvation Bio Inc. (11.49), less than Achilles Therapeutics plc (8.24), less than NextCure, Inc. (8.35), greater than Comera Life Sciences Holdings, Inc. (0.90), greater than SAB Biotherapeutics, Inc. (5.24), greater than Processa Pharmaceuticals, Inc. (4.82), less than Third Harmonic Bio, Inc. (41.13), greater than Unicycive Therapeutics, Inc. (3.37), greater than Quoin Pharmaceuticals, Ltd. (3.35), greater than Cardio Diagnostics Holdings, Inc. (5.69), less than Virax Biolabs Group Limited (25.94), greater than PaxMedica, Inc. Common Stock (2.40), greater than SAB Biotherapeutics, Inc. (5.24), greater than Senti Biosciences, Inc. (4.89), greater than Cingulate Inc. (1.20), greater than Bellicum Pharmaceuticals, Inc. (3.04), greater than Hillstream BioPharma, Inc. (2.25), greater than Blue Water Vaccines, Inc. (0.54), greater than Revelation Biosciences, Inc. (1.10), less than Kiora Pharmaceuticals, Inc. (19.22),

Build a custom stock screener for Fresh Tracks Therapeutics, Inc. (FRTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Fresh Tracks Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Fresh Tracks Therapeutics, Inc. (FRTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Fresh Tracks Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.